Related Experiment Video
Updated: Aug 5, 2026

09:05
MicroRNA-based Regulation of Picornavirus Tropism
Published on: February 6, 2017
Targeting Picornavirus Nonstructural 2C Protein: Structure, Function, and Antiviral Discovery
Kan Li1, Guangjin Fan1, Wenyi Zhang1
1Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey 08552, United States.
ACS Infectious Diseases
|July 27, 2026
Summary
Picornavirus protein 2C is a key target for new antiviral drugs. This review details its structure, function, and potential for developing treatments against picornavirus infections.
Area of Science:
- Virology
- Structural Biology
- Drug Discovery
Background:
- Picornaviruses cause significant human and animal diseases.
- Effective direct-acting antiviral therapies are limited.
- The conserved nonstructural protein 2C plays crucial roles in viral replication.
Purpose of the Study:
- To review the domain architecture and structural biology of picornavirus protein 2C.
- To summarize the experimentally supported roles of 2C in the viral lifecycle.
- To discuss current inhibitors, resistance mutations, and antiviral design strategies targeting 2C.
Main Methods:
- Literature review of structural biology and virology studies.
- Analysis of protein domain architecture and functional activities.
- Comparison of existing antiviral inhibitors and resistance mechanisms.
Main Results:
- Protein 2C possesses ATPase and helicase-like activities.
- Key domains include the N-terminal membrane-binding region, ATPase core, and C-terminal helical domain.
- 2C is implicated in membrane remodeling, RNA replication, and virus-host interactions.
Conclusions:
- Protein 2C is a conserved and essential component of the picornavirus replication machinery.
- Its multifaceted roles and structural features present a promising, yet underexploited, target for antiviral drug development.
- Targeting 2C offers a viable strategy for combating medically important picornaviruses.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

